PRURIGO NODULARIS
Clinical trials for PRURIGO NODULARIS explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to calm relentless itch of prurigo nodularis
Symptom relief TerminatedThis phase 3 study tests rocatinlimab, an injectable drug, against a placebo in 469 adults with prurigo nodularis—a condition causing intense itching and hard bumps on the skin. Participants had not gotten enough relief from topical treatments. The main goal is to see if the drug…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Amgen • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
New drug offers hope for severe itch from skin lumps
Symptom relief TerminatedThis study tested the drug upadacitinib in 5 adults with moderate-to-severe prurigo nodularis, a condition causing very itchy skin bumps. The main goal was to see if it reduces itching by at least 4 points on a scale after 12 weeks. The study was stopped early, so results are lim…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE4 • Sponsor: Psoriasis Treatment Center of Central New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC